GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (XTER:CBHD) » Definitions » Gross Profit

Coloplast AS (XTER:CBHD) Gross Profit : €2,382 Mil (TTM As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Coloplast AS Gross Profit?

Coloplast AS's gross profit for the three months ended in Jun. 2024 was €623 Mil. Coloplast AS's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was €2,382 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Coloplast AS's gross profit for the three months ended in Jun. 2024 was €623 Mil. Coloplast AS's Revenue for the three months ended in Jun. 2024 was €922 Mil. Therefore, Coloplast AS's Gross Margin % for the quarter that ended in Jun. 2024 was 67.51%.

Coloplast AS had a gross margin of 67.51% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Coloplast AS was 68.78%. The lowest was 66.64%. And the median was 68.21%.


Coloplast AS Gross Profit Historical Data

The historical data trend for Coloplast AS's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Gross Profit Chart

Coloplast AS Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,627.93 1,695.61 1,790.34 2,086.51 2,189.47

Coloplast AS Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 540.35 554.07 604.29 600.43 622.76

Competitive Comparison of Coloplast AS's Gross Profit

For the Medical Instruments & Supplies subindustry, Coloplast AS's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Gross Profit distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Gross Profit falls into.



Coloplast AS Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Coloplast AS's Gross Profit for the fiscal year that ended in Sep. 2023 is calculated as

Gross Profit (A: Sep. 2023 )=Revenue - Cost of Goods Sold
=3285.273 - 1095.806
=2,189

Coloplast AS's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=922.488 - 299.725
=623

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,382 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Coloplast AS's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=623 / 922.488
=67.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Coloplast AS  (XTER:CBHD) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Coloplast AS had a gross margin of 67.51% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Coloplast AS Gross Profit Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines